Candice S. Y. Liew, PhD is Senior Scientist at Reprogenix Bioscience, where she leads preclinical and bioprocess development of pluripotent stem cell (PSC)-derived cellular therapies for diabetes. Mentored by Professor Hongkui Deng, Dr. Liew earned her PhD in Cell Biology from Peking University, where her work at the Stem Cell Research Center centered on lineage-specific differentiation of human pluripotent stem cells. In particular, she focused on establishing a state-of-the-art islet differentiation protocol and bench-to-bedside translation of iPSC-derived islets, including systematic preclinical study in diabetic nonhuman-primates. She has authored publications in top-tier journals including Nature Medicine and Cell.
Wednesday, June 11, 2025
6:00 PM – 7:00 PM HK Time